{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:56:49Z","timestamp":1771675009082,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.annder.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T07:47:11Z","timestamp":1656661631000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice"],"prefix":"10.1016","volume":"150","author":[{"given":"N.","family":"Quiles-Tsimaratos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De La Brassinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Telle-Sauvant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Corgibet-Escallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Girardot-Seguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-B.","family":"Duval-Modeste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2022.05.003_bib0160","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2014.530","article-title":"The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries","volume":"135","author":"Dalgard","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0165","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jdv.13891","article-title":"The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials","volume":"31","author":"Fleming","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/1346-8138.14338","article-title":"Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy","volume":"45","author":"Imafuku","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0175","first-page":"626","article-title":"Psoriasis","volume":"87","author":"Weigle","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.annder.2022.05.003_bib0180","first-page":"667","article-title":"Topical long-term therapy of psoriasis with vitamin D(3) analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice","volume":"12","author":"Augustin","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2022.05.003_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2012.04518.x","article-title":"Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists","volume":"26","author":"Paul","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0190","first-page":"1","article-title":"Long-term topical management of psoriasis: the road ahead","author":"Segaert","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2022.05.003_bib0195","first-page":"375","article-title":"Back to the future: a new topical approach for mild-to-moderate psoriasis","volume":"153","author":"Girolomoni","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"3","author":"Devaux","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bjd.15466","article-title":"A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol\/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)","volume":"177","author":"Reich","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdv.12445","article-title":"Non-adherence and measures to improve adherence in the topical treatment of psoriasis","volume":"28","author":"Zschocke","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09546634.2015.1011301","article-title":"Patient-centered treatment\u201d for mild-to-moderate psoriasis","volume":"26","author":"Koetsier","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2022.05.003_bib0220","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjd.15085","article-title":"Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring","volume":"176","author":"Alinia","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09546634.2015.1055228","article-title":"An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium)","volume":"27","author":"Segaert","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2022.05.003_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2288-8-50","article-title":"Vignette studies of medical choice and judgement to study caregivers\u2019 medical decision behaviour: systematic review","volume":"8","author":"Bachmann","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.annder.2022.05.003_bib0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-141-10-200411160-00008","article-title":"Measuring the quality of physician practice by using clinical vignettes: a prospective validation study","volume":"141","author":"Peabody","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2022.05.003_bib0240","unstructured":"Barlet MM, C. Portrait des professionnels de sant\u00e9 - \u00e9dition 2016. Panoramas de la Direction fran\u00e7aise de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques. 2016. https:\/\/drees.solidarites-sante.gouv.fr\/publications\/panoramas-de-la-drees\/portrait-des-professionnels-de-sante-edition-2016."},{"key":"10.1016\/j.annder.2022.05.003_bib0245","first-page":"34","article-title":"Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than cal or BD aerosol foam alone for psoriasis vulgaris: A randomized, double-blind, multicenter, three-arm, phase 2 study","volume":"9","author":"Lebwohl","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0250","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2020.09.037","article-title":"Twice-weekly topical calcipotriene\/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)","volume":"84","author":"Lebwohl","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0255","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/jdv.17435","article-title":"A study of corticophobia in adult psoriasis patients: a French cross-sectional observational study","volume":"35","author":"Moreau","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09546634.2016.1201189","article-title":"Assessment of \u201ccorticophobia\u201d as an indicator of non-adherence to topical corticosteroids: A pilot study","volume":"28","author":"Mueller","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2022.05.003_bib0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4103\/0378-6323.55426","article-title":"The relationship between symptoms and patient characteristics among psoriasis patients","volume":"75","author":"Bilac","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2022.05.003_bib0270","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2133.2004.06093.x","article-title":"Prevalence of symptoms experienced by patients with different clinical types of psoriasis","volume":"151","author":"Sampogna","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0275","first-page":"9","article-title":"How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey","volume":"6","author":"Burroni","year":"2015","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.annder.2022.05.003_bib0280","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jdv.15340","article-title":"Psoriasis Research Group of the French Society of Dermatology. French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults","volume":"33","author":"Amatore","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.05.003_bib0285","unstructured":"Calmus S, Morin S, May-Michelangeli L. Aide \u00e0 l\u2019utilisation de questionnaires patients de mesure des r\u00e9sultats de soins (PROMs) pour am\u00e9liorer la pratique clinique courante. Haute Autorit\u00e9 de Sant\u00e9 France. 2021: 1-31. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-07\/iqss_guide_proms_specifiques_bpco_2021.pdf."},{"key":"10.1016\/j.annder.2022.05.003_bib0290","first-page":"1","article-title":"[S3-guidelines for the treatment of psoriasis vulgaris Update 2011]","volume":"9","author":"Nast","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2022.05.003_bib0295","unstructured":"NICE. Psoriasis: assessment and management. Clinical guideline. 2017 https:\/\/www.nice.org.uk\/guidance\/cg153."},{"key":"10.1016\/j.annder.2022.05.003_bib0300","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1365-2133.2011.10480.x","article-title":"Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis","volume":"165","author":"Pouplard","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.05.003_bib0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13054-016-1266-9","article-title":"Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes","volume":"20","author":"Rhee","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.annder.2022.05.003_bib0310","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12911-016-0377-1","article-title":"Cognitive biases associated with medical decisions: a systematic review","volume":"16","author":"Saposnik","year":"2016","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:31Z","timestamp":1758971431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963822000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0151963822000576"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2022.05.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}